Latest influenza A Stories
First-ever CLIA-waived molecular flu test delivers lab-accurate results at the point of care in less than 15 minutes WALTHAM, Mass., Jan. 7, 2015 /PRNewswire/ -- Alere Inc.
First-ever Platform to Deliver Highly Accurate, Molecular Results in Under 15 Minutes WALTHAM, Mass., June 16, 2014 /PRNewswire/ -- Alere Inc.
Scientists at The University of Texas at Austin have discovered that a protein produced by the influenza A virus helps it outwit one of our body's natural defense mechanisms.
Alere(TM) i Transforms Influenza Testing by Providing Highly Accurate, Molecular Results via a Simple, User-Friendly Platform WALTHAM, Mass., Jan.
Flu symptoms such as fever, nausea, fatigue, headaches, sore throat and body aches can be difficult to deal with, but new research out of Taiwan claims that there may be a radical new possible treatment for such ailments -- methamphetamines.
One drug maker took to the stage on Monday in San Francisco to announce some very encouraging and positive results at the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC).
A team led by scientists at The Scripps Research Institute and Crucell Vaccine Institute in the Netherlands describes three human antibodies that provide broad protection against Influenza B virus strains.
Scientists have found a flu "super antibody" they say may be a turning point in the development of new flu treatments.
The need to create a new flu vaccine annually could be eliminated with a universal influenza vaccine that targets a protein common to all strains of influenza A.
- A volcanic mudflow.